Abstracts Explore
Contact-Force Sensing For Catheter Ablation Procedures at Heart Rhythm 2012
Published on May 15, 2012 at 4:06 AM
By
Will Soutter
Endosense reports
progress in its efforts towards making contact-force sensing as a standard of
care for performing catheter ablation procedures. The company develops
force-sensing technology for improving the safety and efficacy of catheter
ablation procedures for cardiac arrhythmia treatment.
At the
Heart Rhythm 2012, which was held May 9 – 12 in Boston, a new HRS/EHRA/ECAS
expert consensus statement on catheter and surgical ablation of atrial
fibrillation and more than 20 new clinical abstracts were presented on the
importance of sensing in cardiac ablation. Of these, 14 new abstracts were
about the Endosense’s first force-sensing catheter, TactiCath. The instrument
is designed to provide an objective and real-time force when performing the
catheter ablation procedure.
The
first abstract on Endsense’s TactiCath was presented at the Heart Rhythm 2006.
The company has conducted numerous clinical studies to demonstrate the
effectiveness of the sensing technology when compared to ablation technologies.
The
results of Endosense’s EFFICAS II clinical study titled “Contact Force, FTI
[Force Time Integral] and Lesion Continuity Are Critical to Improve Durable PV
Isolation: EFFICAS II Results,” were presented by Dr. Josef Kautzner. Many
other studies demonstrated FTI’s importance for reducing procedure time and for
determining the success of the ablation.
Endosense
has validated contact-force sensing in catheter ablation with its EFFICAS and
TOCCATA studies. The enrollment for the TOCCASTAR investigational device exemption
clinical trial is nearing completion.